Paul Emery
University of Leeds
H-index: 192
Europe-United Kingdom
Top articles of Paul Emery
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Predicting Flare in Patients With Rheumatoid Arthritis in Biologic Induced Remission, on Tapering, and on Stable Therapy | ACR Open Rheumatology | Hanna Gul Andrea Di Matteo Innocent Anioke Farag Shuweidhi Kulveer Mankia | 2024/2/27 |
Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial | The Lancet | Andrew P Cope Marianna Jasenecova Joana C Vasconcelos Andrew Filer Karim Raza | 2024/2/13 |
Filgotinib Demonstrates Efficacy in Rheumatoid Arthritis Independent of Smoking Status: Post Hoc Analysis of Phase 3 Trials and Claims-Based Analysis | Rheumatology and Therapy | Jeffrey R Curtis Paul Emery Bryan Downie Yan Zhong Jinfeng Liu | 2024/2 |
POS0847 UPADACITINIB AS MONOTHERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE TO METHOTREXATE: RESULTS AT 260 WEEKS FROM THE SELECT-MONOTHERAPY STUDY | JS Smolen P Emery W Rigby Y Tanaka J Ignacio Vargas | 2023/6/1 | |
DNA Hypomethylation in the TNF-Alpha Gene Predicts Rheumatoid Arthritis Classification in Patients with Early Inflammatory Symptoms | Cells | Rujiraporn Pitaksalee Rekha Parmar Richard Hodgett Paul Emery Frederique Ponchel | 2023/9/28 |
POS0461 AN INCREASE IN ULTRASOUND JOINT INFLAMMATION OCCURS WHEN ANTI-CCP POSITIVE AT-RISK INDIVIDUALS WITH SUBCLINICAL SYNOVITIS PROGRESS TO INFLAMMATORY ARTHRITIS | K Harnden A Di Matteo D Esperança Almeida E De Lorenzis L Duquenne | 2023/6/1 | |
Rituximab in a Large Uk Centre during the Covid-19 Pandemic: The Effects of Employing a Reduced Dosing Regimen on Clinical Response in Rheumatoid Arthritis Patients | Rheumatology (United Kingdom) | J McLorinan M Slade CH Leong J Baker L Bailey | 2023 |
POS0014 SINGLE-CELL PERIPHERAL BLOOD ANALYSIS IDENTIFIES KEY IMMUNE SIGNATURES ASSOCIATED WITH REFRACTORY RHEUMATOID ARTHRITIS | Y Tan T Bhatt M Sutcliffe J Fitton P Emery | 2023/6/1 | |
P132 A late and rapid increase in ultrasound joint inflammation occurs when anti-CCP positive at-risk individuals with subclinical synovitis progress to inflammatory arthritis | Rheumatology | Kate Harnden Andrea Di Matteo Diogo Esperança Almeida Enrico De Lorenzis Laurence Duquenne | 2023/4/1 |
The trajectory of clinical responses in patients with early rheumatoid arthritis who achieve sustained remission in response to abatacept: subanalysis of AVERT-2, a randomized … | Arthritis Research & Therapy | Paul Emery Yoshiya Tanaka Vivian P Bykerk Clifton O Bingham Thomas WJ Huizinga | 2023/4/22 |
Sustained remission and outcomes with abatacept plus methotrexate following stepwise dose de-escalation in patients with early rheumatoid arthritis | Rheumatology and Therapy | Paul Emery Yoshiya Tanaka Vivian P Bykerk Thomas WJ Huizinga Gustavo Citera | 2023/6 |
Lymphocyte subset phenotyping for the prediction of progression to inflammatory arthritis in anti-citrullinated-peptide antibody-positive at-risk individuals | Rheumatology | Innocent Anioke Laurence Duquenne Rekha Parmar Kulveer Mankia Farag Shuweihdi | 2023/9/7 |
POS0829 SAFETY AND EFFICACY OF FILGOTINIB: AN UPDATE FROM THE DARWIN 3 PHASE 2 LONG-TERM EXTENSION WITH A MAXIMUM OF 8.2 YEARS OF EXPOSURE | R Westhovens R Alten L Dagna A Kavanaugh K Winthrop | 2023/6/1 | |
Valuing Health Gain from Composite Response Endpoints for Multisystem Diseases | Value in health | Sean P Gavan Ian N Bruce Katherine Payne Ian Bruce Mark Lunt | 2023/1/1 |
OP0130 abatacept in individuals at risk of developing rheumatoid arthritis: results from the arthritis prevention in the pre-clinical phase of ra with abatacept (apippra) trial | Andrew Cope Marianna Jasenecova J Vasconcelos Andrew Filer Karim Raza | 2023/6/1 | |
Preclinical or subclinical rheumatoid arthritis-associated interstitial lung disease: misleading terms with potentially deleterious consequences | The Lancet Rheumatology | Elizabeth R Volkmann Jeffrey A Sparks Anna-Maria Hoffmann-Vold Tracy J Doyle Paul Emery | 2023/3/1 |
P137 First-line tumour necrosis factor inhibitor (TNFi) treatment is associated with high multi-criteria remission early on compared to treat-to-target in a treatment naïve RA … | Rheumatology | Rudresh Shukla Darren Plant Paul Emery Maya H Buch | 2023/4/1 |
Predictors of BILAG-based outcomes in patients with SLE: Analysis from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort | Lupus | Trixy David Li Su Yafeng Cheng Caroline Gordon Benjamin Parker | 2023/8 |
Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update | Annals of the rheumatic diseases | Daniel Aletaha Andreas Kerschbaumer Kastriot Kastrati Christian Dejaco Maxime Dougados | 2023/6/1 |
POS0484 HIGH ANTI-CCP LEVEL AND FEMALE GENDER ARE ASSOCIATED WITH PROGRESSION TO PERSISTENT ARTHRITIS IN PATIENTS WITH PALINDROMIC RHEUMATISM; RESULTS OF A UK PROSPECTIVE … | R Chowdhury F Shuweihdi N Sidhu L Duquenne L Garcia-Montoya | 2023/6/1 |
Co-Authors
